RGD Reference Report - MAPK kinase 3 is a tumor suppressor with reduced copy number in breast cancer. - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

MAPK kinase 3 is a tumor suppressor with reduced copy number in breast cancer.

Authors: Macneil, AJ  Jiao, SC  McEachern, LA  Yang, YJ  Dennis, A  Yu, H  Xu, Z  Marshall, JS  Lin, TJ 
Citation: Macneil AJ, etal., Cancer Res. 2013 Nov 14.
RGD ID: 7495808
Pubmed: PMID:24233520   (View Abstract at PubMed)
DOI: DOI:10.1158/0008-5472.CAN-13-1310   (Journal Full-text)

Cancers are initiated as a result of changes that occur in the genome. Identification of gains and losses in the structure and expression of tumor suppressor genes and oncogenes lies at the root of the understanding of cancer cell biology. Here we show that the MAPK kinase MKK3 suppresses the growth of breast cancer where it varies in copy number. A pervasive loss of MKK3 gene copy number in breast cancer patients is associated with an impairment of MKK3 expression and protein level in malignant tissues. To assess the functional role of MKK3 in breast cancer, we showed in an animal model that MKK3 activity is required for suppression of tumor growth. Active MKK3 enhanced expression of the cyclin-dependent kinase inhibitors p21Cip1/Waf1 and p27Kip1, leading to increased cell cycle arrest in G1 phase of the cell cycle. Our results reveal the functional significance of MKK3 as a tumor suppressor and improve understanding of the dynamic role of the MAPK pathway in tumor progression.

Objects Annotated

Genes (Rattus norvegicus)
Map2k3  (mitogen activated protein kinase kinase 3)

Genes (Mus musculus)
Map2k3  (mitogen-activated protein kinase kinase 3)

Genes (Homo sapiens)
MAP2K3  (mitogen-activated protein kinase kinase 3)


Additional Information